John M. Burke, Enrico De Nigris, Yunfei Wang, Kathleen Aguilar, John Murphy, Brittani Wayne, Jennifer Prescott, Diana Chirovsky, Inkyu Kim, Siyang Leng, Ira Zackon. "Correlation between real-world (RW) progression-free survival (rwPFS) and overall survival (OS) among patients (Pts) with first-line (1L) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) receiving covalent bruton tyrosine kinase inhibitors (cBTKis) or B-cell lymphoma 2 inhibitors (BCL2is)." Blood (2025). https://doi.org/10.1182/blood-2025-3888